“…We thank Xue et al for giving us the opportunity to clarify and emphasise some methodological aspects of our study and we are pleased to respond to their accurate observation 2. First, in our trial, SFICB was used in the context of multimodal analgesia, including Cox-2-selective non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen and dexamethasone.…”